# Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes Mellitus

> **NCT06196996** · NA · RECRUITING · sponsor: **Shanghai Changzheng Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Brittle Type 1 Diabetes Mellitus

## Interventions

- **PROCEDURE:** The method of islet transplantation is through percutaneous transhepatic portal vein puncture.

## Key facts

- **NCT ID:** NCT06196996
- **Lead sponsor:** Shanghai Changzheng Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-14
- **Primary completion:** 2025-12
- **Final completion:** 2026-09
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06196996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06196996, "Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06196996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*